MOLN.SW
Molecular Partners AG
Price:  
5.05 
CHF
Volume:  
6,771.00
Switzerland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MOLN.SW WACC - Weighted Average Cost of Capital

The WACC of Molecular Partners AG (MOLN.SW) is 6.8%.

The Cost of Equity of Molecular Partners AG (MOLN.SW) is 6.75%.
The Cost of Debt of Molecular Partners AG (MOLN.SW) is 7.00%.

Range Selected
Cost of equity 5.00% - 8.50% 6.75%
Tax rate -% - -% -%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.0% - 8.5% 6.8%
WACC

MOLN.SW WACC calculation

Category Low High
Long-term bond rate 1.0% 1.5%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.39 0.75
Additional risk adjustments 2.0% 2.5%
Cost of equity 5.00% 8.50%
Tax rate -% -%
Debt/Equity ratio 0.02 0.02
Cost of debt 7.00% 7.00%
After-tax WACC 5.0% 8.5%
Selected WACC 6.8%